FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods

On 21 JAN 2026 , the U.S. Food and Drug Administration issued a Request for Information (RFI) regarding labeling and preventing cross-contact of gluten in packaged food. The FDA is taking this action as a first step to improve transparency in disclosures of ingredients that impact certain health conditions, such as gluten for those with celiac disease, and other established food allergens.

Research breakthrough could help regrow lost limbs:  A team from Texas A&M University has uncovered a key to joint regeneration.

Researchers take a step toward limb regeneration: In a significant step toward full-limb regeneration, researchers at Texas A&M University have identified a fibroblast growth factor as a key protein that can regenerate an entire finger joint, including soft tissue. “Our expectation is that if we can figure out all the factors that regenerate a finger, then we could apply those factors anywhere on the rest of the arm, or even a leg, and regrow a limb,” said Assistant Professor Lindsay Dawson.

FDA questions on generative AI-enabled chatbots raise concerns from expert panel

During the second meeting of the US Food and Drug Administration’s (FDA) Digital Health Advisory Committee (DHAC), members of the panel seemed shocked and, at times, lost for words when grappling with the Agency’s discussion questions surrounding the potential regulation of generative Artificial intelligence (AI)-enabled digital mental health medical.